In OCC 2026 Quest for Truth roundtable, leading cardiovascular experts from China and Australia gather to discuss “Hypertension · Cornerstone Chapter — From Blood Pressure Management to Root-Cause Innovation”. The session is hosted by Prof. Gang Wu, Shanghai General Hospital, and co-hosted by Prof. Dongying Zhang, The First Affiliated Hospital of Chongqing Medical University. Quest for Truth is honored to welcome two distinguished guest speakers: Prof. Xiangqing Kong, The First Affiliated Hospital with Nanjing Medical University; and Prof. Alberto P. Avolio, Macquarie University, Australia.
The roundtable focuses on how hypertension care may evolve from numerical blood pressure control toward mechanism-based and precision-oriented management. The experts discuss the limitations of lifelong medication, the low global control rate of hypertension, central nervous system regulation, perirenal adipose tissue as a potential therapeutic target, arterial stiffness and hemodynamic mechanisms, cuffless and wearable blood pressure monitoring, clinical validation standards, and the future role of Chinese innovation in reshaping global hypertension treatment.
In this segment, Prof. Alberto P. Avolio discusses the promise and limitations of cuffless wearable blood pressure monitoring. He explains that while the ultimate goal is an accurate wearable device that can measure blood pressure without a cuff, the challenge remains highly complex because blood pressure is a force, and cuffless technologies rely on surrogate signals such as arterial pulse waveforms rather than direct pressure measurement.
Prof. Avolio emphasizes that wearable devices may first play an important role in improving awareness, helping people recognize possible hypertensive conditions and seek medical evaluation. He also highlights the importance of calibration, validation standards, and clinical trust, noting that blood pressure should not be understood as a single number, but as a dynamic profile that changes with physiology and may support more personalized hypertension management.